Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
|
Clinic notes were received reporting that the patient experienced chest pain, dyspnea, and coughing associated with the stimulation.The physician attempted to adjust the patient's parameters; however, the patient was admitted to the hospital due to the experienced events.The patient's symptoms were resolved when the stimulation was inhibited with the magnet.Response was received that the medical intervention was to prevent a serious injury.No other relevant information has been received to date.
|